Effects of delayed cord clamping in intrauterine growth-restricted neonates: a randomized controlled trial

Kanhu Charan Digal1, Poonam Singh1, Yash Srivastava2

  • 1Department of Neonatology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, 249203, India.

Insights

Delayed cord clamping (DCC) improves systemic blood flow and iron levels in intrauterine growth-restricted (IUGR) neonates. This safe intervention increases blood flow and hematocrit without raising risks of polycythemia or phototherapy needs.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Perinatal Research

Background:

  • The optimal timing for umbilical cord clamping in intrauterine growth-restricted (IUGR) neonates is not well-established.
  • Delayed cord clamping (DCC) has shown benefits in preterm infants but concerns remain regarding potential risks in IUGR neonates.

Purpose of the Study:

  • To compare the effects of delayed cord clamping (DCC) versus early cord clamping (ECC) on systemic blood flow and cerebral hemodynamics in IUGR neonates.
  • To evaluate the safety and efficacy of DCC in IUGR infants.

Main Methods:

  • A randomized controlled trial involving IUGR neonates (gestational age ≥28 weeks) not requiring resuscitation.
  • Infants were randomized to DCC (clamping after 60s) or ECC (clamping within 30s).
  • Primary outcome was superior vena cava (SVC) blood flow at 24±2h; secondary outcomes included various hemodynamic parameters, hematocrit, bilirubin levels, and clinical outcomes.

Main Results:

  • DCC significantly increased SVC blood flow, right ventricular output (RVO), superior mesenteric artery blood flow velocity (SMA-BFV), venous hematocrit, and serum ferritin levels compared to ECC.
  • While peak total serum bilirubin (TSB) was higher with DCC, the duration of phototherapy was comparable.
  • Incidences of polycythemia, intraventricular hemorrhage, and other adverse outcomes were similar between the groups.

Conclusions:

  • Delayed cord clamping is a safe and beneficial intervention for IUGR neonates.
  • DCC improves systemic blood flow, SMA-BFV, hematocrit, and serum ferritin levels.
  • DCC does not increase the risk of polycythemia or the need for phototherapy for hyperbilirubinemia in this population.

Related Concept Videos